September 2006. Volume 2. Number 3

BCG vaccination during the newborn period is cost-effective and effective against meningitis and miliary tuberculosis in low-income countries

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Trunz BB, Fine PEM, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006;367:1173-80
Reviewers: Buñuel Álvarez JC1, Olivares Grohnert M2.
1Àrea Bàsica de Salut Girona-4. Institut Català de la Salut. Girona. España.
2Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile. Santiago. Región Metropolitana. Chile.
Correspondence: José Cristóbal Buñuel Álvarez. Email: jcbunuel@gmail.com
Reception date: 10/07/2006
Acceptance date: 23/07/2006
Publication date: 01/09/2006

Abstract


How to cite this article

Buñuel Álvarez JC, Olivares Grohnert M. La vacuna BCG administrada al nacimiento o en los primeros días de vida es coste-efectiva y eficaz para la prevención de casos de meningitis tuberculosa y tuberculosis miliar en países de baja renta. Evid Pediatr. 2006;2:56.

AVC | Critically appraised articles

Trunz BB, Fine PEM, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006;367:1173-80
Reviewers: Buñuel Álvarez JC1, Olivares Grohnert M2.
1Àrea Bàsica de Salut Girona-4. Institut Català de la Salut. Girona. España.
2Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile. Santiago. Región Metropolitana. Chile.
Correspondence: José Cristóbal Buñuel Álvarez. Email: jcbunuel@gmail.com
Reception date: 10/07/2006
Acceptance date: 23/07/2006
Publication date: 01/09/2006

How to cite this article

Buñuel Álvarez JC, Olivares Grohnert M. La vacuna BCG administrada al nacimiento o en los primeros días de vida es coste-efectiva y eficaz para la prevención de casos de meningitis tuberculosa y tuberculosis miliar en países de baja renta. Evid Pediatr. 2006;2:56.

References

  1. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995;96:29-35.
  2. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993;22:1154-8.
  3. World Health Organization. BCG in immunization programmes. Wkly Epidemiol Rec. 2001;76:33-40.
  4. Hersh AL, Tala-Heikkila M, Tala E, Tosteson AN, Fordham von Reyn C. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guerin in Finland. Int J Tuberc Lung Dis. 2003;7:22-9.
  5. Rahman M, Sekimoto M, Takamatsu I, Hira K, Shimbo T, Toyoshima K, et al. Economic evaluation of universal BCG vaccination of Japanese infants. Int J Epidemiol. 2001;30:380-5.
  6. Borgdorff MW, Floyd K, Broekmans JF. Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull World Health Organ. 2002;80:217-27.
  7. Altet MN, Alcalde J. Control y eliminación de la tuberculosis en España: las estrategias para el siglo XXI. An Pediatr (Barc). 2006;64:66-73.
01/09/2006

Linked Comment